Arkolith/Insider Trading/ENOB/Form 4

Dybul Mark

Chief Executive Officer, DirectorEnochian Biosciences Inc (ENOB) · full profile →Form 4 · filed Jul 22, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 19, 2021Grant(A)2.0M—$02.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-21-001219) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML